Locally advanced Urothelial Carcinoma
Drug | Drug Name | Drug Description |
---|---|---|
DB11945 | Avelumab | An anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma. |
DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05015 | Belinostat | 1 | Recruiting | 1 |
DB08875 | Cabozantinib | 1 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB11714 | Durvalumab | 1 | Recruiting | 1 |
DB13007 | Enfortumab vedotin | 1 | Recruiting | 2 |
DB12147 | Erdafitinib | 1 | Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Recruiting | 2 |
DB00020 | Sargramostim | 1 | Recruiting | 1 |
DB09143 | Sonidegib | 1 | Recruiting | 1 |
DB08871 | Eribulin | 1 / 2 | Active Not Recruiting | 1 |
DB01175 | Escitalopram | 1 / 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
DB11942 | Selinexor | 1 / 2 | Recruiting | 1 |
DB12887 | Tazemetostat | 1 / 2 | Active Not Recruiting | 1 |
DB11945 | Avelumab | 2 | Recruiting | 1 |
DB13007 | Enfortumab vedotin | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 3 |
DB09037 | Pembrolizumab | 2 | Recruiting | 2 |
DB00571 | Propranolol | 2 | Recruiting | 1 |
DB14851 | Relatlimab | 2 | Recruiting | 1 |
DB11595 | Atezolizumab | 3 | Active Not Recruiting | 1 |
DB11945 | Avelumab | 3 | Active Not Recruiting | 1 |
DB11714 | Durvalumab | 3 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 3 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 3 | Active Not Recruiting | 2 |
DB12147 | Erdafitinib | Not Available | Terminated | 1 |